Kimberly S. Taylor Sells 2,300 Shares of CME Group Inc. (CME) Stock
CME Group Inc. (NASDAQ:CME) insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction on Thursday, September 29th. The shares were sold at an average price of $106.01, for a total value of $243,823.00. Following the completion of the sale, the insider now directly owns 105,558 shares in the company, valued at approximately $11,190,203.58. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Shares of CME Group Inc. (NASDAQ:CME) opened at 104.52 on Friday. The company has a 50-day moving average price of $106.83 and a 200-day moving average price of $99.14. CME Group Inc. has a 12 month low of $81.87 and a 12 month high of $110.35. The company has a market capitalization of $35.42 billion, a price-to-earnings ratio of 26.39 and a beta of 0.85.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.03. The firm had revenue of $906 million for the quarter, compared to the consensus estimate of $897.84 million. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company’s revenue was up 10.5% on a year-over-year basis. During the same period last year, the firm earned $0.95 EPS. On average, equities analysts anticipate that CME Group Inc. will post $4.44 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.30%. CME Group’s dividend payout ratio is currently 60.61%.
CME has been the topic of a number of research analyst reports. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a report on Monday, June 20th. Credit Agricole SA cut their price objective on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a report on Thursday, July 14th. Barclays PLC cut their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a report on Friday, July 29th. Deutsche Bank AG raised their price objective on CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a report on Friday, July 29th. Finally, Keefe, Bruyette & Woods raised their price objective on CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $102.89.
Hedge funds have recently made changes to their positions in the stock. Glenmede Trust Co. NA increased its stake in shares of CME Group by 2.2% in the first quarter. Glenmede Trust Co. NA now owns 32,517 shares of the company’s stock worth $3,122,000 after buying an additional 710 shares in the last quarter. Virginia Retirement System bought a new stake in shares of CME Group during the first quarter worth about $500,000. CIBC World Markets Inc. bought a new stake in shares of CME Group during the first quarter worth about $860,000. Ngam Advisors L.P. increased its stake in shares of CME Group by 8.9% in the first quarter. Ngam Advisors L.P. now owns 37,903 shares of the company’s stock worth $3,641,000 after buying an additional 3,094 shares in the last quarter. Finally, TIAA CREF Investment Management LLC increased its stake in shares of CME Group by 21.8% in the first quarter. TIAA CREF Investment Management LLC now owns 989,117 shares of the company’s stock worth $95,005,000 after buying an additional 176,790 shares in the last quarter. Institutional investors own 80.29% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.